The impact of MetS components is significant with or without changes to insulin production, sensitivity, and target tissue resistance or diabetes, further supporting that more than one pattern or process of metabolic dysregulation contributes to the development of MetS components and disease states over time. The gene discussed is INS; the disease is diabetes mellitus.